Medigene : CV Dr. Gerd Zettlmeissl - MarketScreener
Annual general meeting of Medigene AG on 24 June 2024 Convenience Translation Gerd Zettlmeissl, PhD ...
Stay updated with breaking news from Themis Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Annual general meeting of Medigene AG on 24 June 2024 Convenience Translation Gerd Zettlmeissl, PhD ...
Here are eight Austrian biotech companies that have received funding in recent years to propel their pioneering innovations forward.
European biotech AlgoTx, the developer of first-in-class treatment ATX01 for chemotherapy-induced peripheral neuropathy (CIPN), announced today the success of a €20M Series B fundraising led by Relyens
Major players in the cancer vaccines market are GlaxoSmithKline, Merck, Aduro Biotech, Astrazeneca Plc, Dendreon, Astellas Pharma Inc, Sanofi Pasteur,...
Climate change and other environmental factors could cause Lassa fever to spread to additional regions within Africa, new research predicts. CEPI is the leading funder of research into vaccines against the potentially deadly virus.